Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients
El Sharouni, Mary Ann; Scolyer, Richard A.; van Gils, Carla H.; Ch'ng, Sydney; Nieweg, Omgo E.; Pennington, Thomas E.; Saw, Robyn PM; Shannon, Kerwin; Spillane, Andrew; Stretch, Jonathan; Witkamp, Arjen J.; Sigurdsson, Vigfús; Thompson, John F.; van Diest, Paul J.; Lo, Serigne N.
(2022) European Journal of Cancer, volume 167, pp. 133 - 141
(Article)
Abstract
Introduction: This study sought to assess whether the interval between diagnostic excision-biopsy of a primary melanoma and definitive wide excision with sentinel node biopsy (SNB) influenced the size of SN metastatic deposits, which might have implications for management and prognosis. Methods: Data were collected for (i) a Dutch population-based cohort
... read more
of patients treated between 2004 and 2014 who underwent SNB within 100 days of complete excision of their primary melanoma and who were SN-positive with known SN metastasis diameter (n = 1027) and (ii) a cohort from a large Australian melanoma treatment centre (n = 541) who presented in the same time period. The effects of SNB timing on the size of SN metastatic deposits were analysed. Results: Dutch patients whose SNB was performed in the second or third months after diagnosis had significantly larger SN metastasis diameters than patients who had their SNB in the first month (median increases of 17% (95%CI -14, 60%, p = 0.211) and 71% (95%CI 15, 119%, p = 0.004), respectively). No significant difference in tumour diameter for early and late SNB was found in the Australian cohort. Conclusions: SN metastasis diameter became progressively greater with SN biopsy in the second and third months after primary melanoma diagnosis in the larger, population-based patient cohort. An increase in metastasis diameter was not observed in the smaller, institutional cohort, possibly due to detection of larger SN metastases by routine pre-operative ultrasound, with fine-needle biopsy confirmation. These patients did not proceed to SNB and were therefore not included in the study.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Diagnosis, Excision, Melanoma, Metastasis, Sentinel node, Size, Time, Lymph Node Excision, Melanoma/pathology, Humans, Syndrome, Skin Neoplasms/pathology, Extranodal Extension, Sentinel Lymph Node Biopsy, Australia, Neoplasms, Second Primary/surgery, Oncology, Cancer Research, Journal Article
ISSN: 0959-8049
Publisher: Elsevier Limited
Note: Funding Information: MAES was supported by a Research Fellowship Grant from the European Academy of Dermatology and Venereology (EADV). RAS and JFT are recipients of an Australian National Health and Medical Research Council (NHMRC) Program Grant. RAS is also supported by an NHMRC Fellowship (APP1141295). Additionally, this research was supported by research program grants from Cancer Institute New South Wales and the NHMRC. SNL and RPMS are supported by Melanoma Institute Australia. Support from the Cameron Family and the Ainsworth Foundation is also gratefully acknowledged.JFT has received honoraria for advisory board participation from Merck Sharpe & Dohme Australia and Bristol Myers Squibb Australia, honoraria and travel expenses from GlaxoSmithKline and Provectus Inc, and support for conference attendance from Novartis.RPMS has received honoraria for advisory board participation from MSD, Novartis and Qbiotics and speaking honoraria from BMS.AJS has received honoraria for advisory board participation from Qbiotics, Novartis and Stryker. Publisher Copyright: © 2022 Elsevier Ltd
(Peer reviewed)